Research

  1. 2020
  2. 2019
  3. Berger, G., Gerritsen, M., Yi, G., Koorenhof-Scheele, T. N., Kroeze, L. I., Stevens-Kroef, M., Yoshida, K., Shiraishi, Y., van den Berg, E., Schepers, H., Huls, G., Mulder, A. B., Ogawa, S., Martens, J. H. A., Jansen, J. H., & Vellenga, E. (2019). Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern. Blood, 3(20), 3111-3122. https://doi.org/10.1182/bloodadvances.2019000518
  4. Rack, K. A., van den Berg, E., Haferlach, C., Beverloo, H. B., Costa, D., Espinet, B., Foot, N., Jeffries, S., Martin, K., O'Connor, S., Schoumans, J., Talley, P., Telford, N., Stioui, S., Zemanova, Z., & Hastings, R. J. (2019). European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms. Leukemia, 33(8), 1851-1867. https://doi.org/10.1038/s41375-019-0378-z
  5. 2018
  6. Holand, M., Kolberg, M., Danielsen, S. A., Bjerkehagen, B., Eilertsen, I. A., Hektoen, M., Mandahl, N., van den Berg, E., Smeland, S., Mertens, F., Hall, K. S., Picci, P., Sveen, A., & Lothe, R. A. (2018). Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53. Modern Pathology, 31(11), 1694-1707. https://doi.org/10.1038/s41379-018-0074-y
  7. Berger, G., Kroeze, L. I., Koorenhof-Scheele, T. N., de Graaf, A. O., Yoshida, K., Ueno, H., Shiraishi, Y., Miyano, S., van den Berg, E., Schepers, H., van der Reijden, B. A., Ogawa, S., Vellenga, E., & Jansen, J. H. (2018). Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCT. Blood, 131(16), 1846-1857. https://doi.org/10.1182/blood-2017-09-805879
  8. 2017
  9. 2016
  10. Schoumans, J., Suela, J., Hastings, R., Muehlematter, D., Rack, K., van den Berg, E., Beverloo, H. B., & Stevens-Kroef, M. (2016). Guidelines for genomic array analysis in acquired haematological neoplastic disorders. GENES CHROMOSOMES & CANCER, 55(5), 480-491. https://doi.org/10.1002/gcc.22350
  11. Hastings, R. J., Bown, N., Tibiletti, M. G., Debiec-Rychter, M., Vanni, R., Espinet, B., van Roy, N., Roberts, P., Berg-de Ruiter, van den, E., Bernheim, A., Schoumans, J., Chatters, S., Zemanova, Z., Stevens-Kroef, M., Simons, A., Heim, S., Salido, M., Ylstra, B., & Betts, D. R. (2016). Guidelines for cytogenetic investigations in tumours. European Journal of Human Genetics, 24(1), 6-13. https://doi.org/10.1038/ejhg.2015.35
  12. 2015
  13. Danielsen, S. A., Lind, G. E., Kolberg, M., Holand, M., Bjerkehagen, B., Hall, K. S., van den Berg, E., Mertens, F., Smeland, S., Picci, P., & Lothe, R. A. (2015). Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis. Neuro-Oncology, 17(1), 63-69. https://doi.org/10.1093/neuonc/nou140
  14. 2014
  15. de Vree, P. J. P., de Wit, E., Yilmaz, M., de Heijning, M. V., Klous, P., Verstegen, M. J. A. M., Wan, Y., Teunissen, H., Krijger, P. H. L., Geeven, G., Eijk, P. P., Sie, D., Ylstra, B., Hulsman, L. O. M., van Dooren, M. F., van Zutven, L. J. C. M., van den Ouweland, A., Verbeek, S., van Dijk, K. W., ... de Laat, W. (2014). Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping. Nature Biotechnology, 32(10), 1019-1025.e2. https://doi.org/10.1038/nbt.2959
  16. Van Den Berg-De Ruiter, E., van Min, M., Mulder, A., Vellenga, E., Splinter, E., de Wit, E., Klous, P., van der Vlies, P., Weening, D., van Diemen, C., Sijmons, R., Sinke, R., & Raddatz, B. (2014). A comprehensive new DNA test for detection of fusion genes in leukemia. Haematologica, 99, 276-276.
  17. Havik, A. B., Lind, G. E., Honne, H., Meling, T. R., Scheie, D., Hall, K. S., van den Berg-de Ruiter, E., Mertens, F., Picci, P., Lothe, R. A., Heim, S., & Brandal, P. (2014). Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors. Neuro-Oncology, 16(2), 320-322. https://doi.org/10.1093/neuonc/not230
  18. 2013
  19. 2012
  20. 2011
  21. Simons, A., Stevens-Kroef, M., El Idrissi-Zaynoun, N., van Gessel, S., Weghuis, D. O., van den Berg, E., Waanders, E., Hoogerbrugge, P., Kuiper, R., & van Kessel, A. G. (2011). Microarray-Based Genomic Profiling as a Diagnostic Tool in Acute Lymphoblastic Leukemia. GENES CHROMOSOMES & CANCER, 50(12), 969-981. https://doi.org/10.1002/gcc.20919
  22. 2010
  23. Lugthart, S., Groschel, S., Beverloo, H. B., Kayser, S., Valk, P. J. M., van Zelderen-Bhola, S. L., Ossenkoppele, G. J., Vellenga, E., van den Berg-de Ruiter, E., Schanz, U., Verhoef, G., Vandenberghe, P., Ferrant, A., Kohne, C-H., Pfreundschuh, M., Horst, H. A., Koller, E., von Lilienfeld-Toal, M., Bentz, M., ... Doehner, H. (2010). Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia. Journal of Clinical Oncology, 28(24), 3890-3898. https://doi.org/10.1200/JCO.2010.29.2771
  24. Harrison, C. J., Hills, R. K., Moorman, A. V., Grimwade, D. J., Hann, I., Webb, D. K. H., Wheatley, K., de Graaf, S. S. N., van den Berg, E., Burnett, A. K., & Gibson, B. E. S. (2010). Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12. Journal of Clinical Oncology, 28(16), 2674-2681. https://doi.org/10.1200/JCO.2009.24.8997
  25. Brekke, H. R., Ribeiro, F. R., Kolberg, M., Agesen, T. H., Lind, G. E., Eknaes, M., Hall, K. S., Bjerkehagen, B., van den Berg, E., Teixeira, M. R., Mandahl, N., Smeland, S., Mertens, F., Skotheim, R. I., & Lothe, R. A. (2010). Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group. Journal of Clinical Oncology, 28(9), 1573-1582. https://doi.org/10.1200/JCO.2009.24.8989
  26. 2009
  27. Veerman, A. J., Kamps, W. A., van den Berg, H., van den Berg, E., Bokkerink, J. P. M., Bruin, M. C. A., van den Heuvel-Eibrink, M. M., Korbijn, C. M., Korthof, E. T., van der Pal, K., Stijnen, T., Sipman, M. H. V. W., Weerden, van, F., van Wering, E. R., van der Does-van den Berg, A., & Dutch Childhood Oncology Grp (2009). Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncology, 10(10), 957-966. https://doi.org/10.1016/S1470-2045(09)70228-1
  28. Bottillo, I., Ahiquist, T., Brekke, H., Danielsen, S. A., van den Berg, E., Mertens, F., Lothe, R. A., & Dallapiccola, B. (2009). Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours. JOURNAL OF PATHOLOGY, 217(5), 693-701. https://doi.org/10.1002/path.2494
  29. 2007
  30. 2006
  31. 2005
  32. 2004
  33. 2003
  34. Komdeur, R., Hoekstra, HJ., Molenaar, WM., van den Berg, E., Zwart, N., Pras, E., Plaza-Menacho, N. V., Hofstra, RMW., & van der Graaf, WTA. (2003). Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target. Clinical Cancer Research, 9(8), 2926-2932.
  35. Komdeur, R., Klunder, J., van der Graaf, WTA., van den Berg, E., de Bont, ESJM., Hoekstra, HJ., & Molenaar, WM. (2003). Multidrug resistance proteins in rhabdomyosarcomas - Comparison between children and adults. Cancer, 97(8), 1999-2005. https://doi.org/10.1002/cncr.11259
Previous 1 2 Next

ID: 136108